Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B W Day

Showing results (61-70 of 63) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 63 results.
Molecular Pharmacology|January 28, 1998
Structure-activity analysis of the interaction of curacin A, the potent colchicine site antimitotic agent, with tubulin and effects of analogs on the growth of MCF-7 breast cancer cellsP Verdier-Pinard, J Y Lai, H D Yoo, et al.
Oncogenesis|May 16, 2017
Cyclin-dependent kinase 7 is a therapeutic target in high-grade gliomaS A Greenall, Y C Lim, C B Mitchell, et al.
British Journal of Cancer|December 15, 2015
Patient-derived glioblastoma cells show significant heterogeneity in treatment responses to the inhibitor-of-apoptosis-protein antagonist birinapantZ Zakaria, A Tivnan, L Flanagan, et al.
Pageof 7

Showing results (61-70 of 63) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 63 results.
Molecular Pharmacology|January 28, 1998
Structure-activity analysis of the interaction of curacin A, the potent colchicine site antimitotic agent, with tubulin and effects of analogs on the growth of MCF-7 breast cancer cellsP Verdier-Pinard, J Y Lai, H D Yoo, et al.
Oncogenesis|May 16, 2017
Cyclin-dependent kinase 7 is a therapeutic target in high-grade gliomaS A Greenall, Y C Lim, C B Mitchell, et al.
British Journal of Cancer|December 15, 2015
Patient-derived glioblastoma cells show significant heterogeneity in treatment responses to the inhibitor-of-apoptosis-protein antagonist birinapantZ Zakaria, A Tivnan, L Flanagan, et al.
Pageof 7